Overview of Blood Cancer Care Services at Artemis Hospitals
At Artemis Hospitals, our blood cancer department works best because we use different ways together to treat patients. As a premier facility, we prioritise advanced diagnostic infrastructure, such as high-end flow cytometry and molecular testing, to ensure precise disease typing.
The availability of dedicated Bone Marrow Transplant (BMT) units with HEPA-filtered environments is crucial for preventing infections in the patient. Furthermore, 24/7 access to a specialised blood bank and comprehensive pharmacy services ensures that intensive treatments like chemotherapy proceed without delay.
By integrating these clinical services with compassionate nursing and nutritional support, the hospital creates an environment optimised for the patient’s recovery and long-term health.
Conditions Treated at Haemato-Oncology Department
The Haemato-Oncology Department at Artemis Hospitals provides expert care for a diverse range of primary and secondary blood disorders. Utilising ultra-modern molecular diagnostics, the clinical team develops targeted strategies to manage both malignant and non-malignant conditions effectively. This specialised focus ensures that the patient receives a precise treatment plan tailored to the unique biological signature of their haematological health.
Leukemia (Acute and Chronic)
The patient often experiences deep, aching bone and joint pain caused by the rapid accumulation of cancerous white blood cells within the bone marrow. This internal pressure can lead to significant discomfort, especially in the long bones and hips. Additionally, as the disease progresses, an enlarged spleen or liver can cause abdominal fullness and sharp pain in the upper left quadrant.
Lymphoma (Hodgkin and Non-Hodgkin)
Pain in lymphoma is frequently associated with the swelling of lymph nodes, which may press against adjacent nerves, organs, or blood vessels. If the disease involves the chest or abdomen, the patient may suffer from a persistent cough, chest pressure, or severe abdominal cramping. In cases where the malignancy infiltrates the bones or spinal cord, localized and radiating nerve pain can become quite intense.
Multiple Myeloma
This condition is notorious for causing debilitating skeletal pain, particularly in the back, ribs, and skull. The cancer cells activate osteoclasts that break down bone tissue, leading to "lytic lesions" and painful pathological fractures. The patient may also experience sharp, electric-like nerve pain if weakened vertebrae collapse and compress the spinal nerves, a condition requiring immediate medical attention.
Myelodysplastic Syndromes (MDS)
While MDS is often characterized by extreme fatigue, the patient may experience physical pain due to frequent, systemic infections or bleeding complications. If the marrow becomes hypercellular, a dull, heavy sensation in the bones may occur. Furthermore, the patient might suffer from painful mouth sores or skin infections because the body lacks the healthy white blood cells needed to manage inflammation and heal tissue.
Bone Marrow Failure Disorders
In these disorders, the primary source of physical distress for the patient often stems from severe anemia and low platelet counts. This can manifest as intense, throbbing headaches and chest pain due to the heart working harder to circulate oxygen. Additionally, the patient may experience painful bruising or spontaneous bleeding into the joints and soft tissues, which causes localized swelling and significant tenderness.
Common Blood Cancer Cases Managed at Best Blood Cancer Hospital in India
Artemis Hospitals specialises in the management of a wide array of complex haematological conditions, ranging from aggressive leukaemias to chronic plasma cell disorders. The expert team employs a disease-specific approach, and the facility maintains the clinical proficiency required to deliver successful outcomes for even the most challenging blood cancer diagnoses.
Acute Myeloid Leukemia (AML)
For AML, the clinical team prioritizes rapid induction chemotherapy to clear the blood and bone marrow of blasts. Once remission is achieved, consolidation therapy is administered to prevent relapse. For high-risk cases or those with specific genetic mutations, the expert advice often includes an allogeneic bone marrow transplant to replace the patient’s diseased myeloid cells with healthy donor stem cells, ensuring a more durable long-term recovery.
Acute Lymphoblastic Leukemia (ALL)
Treatment for ALL typically follows a multi-phase protocol consisting of induction, intensification, and a long-term maintenance phase. Experts often utilize targeted therapies and specialized chemotherapy combinations tailored to the patient’s age and subtype. Because lymphoblastic cells can migrate to the central nervous system, prophylactic therapy is integrated into the plan to protect the patient from sanctuary site involvement and ensure comprehensive disease eradication.
Chronic Myeloid Leukemia (CML)
The management of CML has been revolutionized by targeted oral therapies known as Tyrosine Kinase Inhibitors (TKIs). These medications specifically block the BCR-ABL protein that drives the overproduction of white blood cells. Experts closely monitor the patient’s molecular response via BCR-ABL1 testing. In rare cases where TKI resistance occurs, specialists may recommend a bone marrow transplant as a curative secondary intervention.
Hodgkin Lymphoma
For Hodgkin Lymphoma, specialists typically advise a combination of chemotherapy protocols, such as ABVD, sometimes followed by precision radiation therapy to target involved lymph node regions. The treatment plan is highly successful and focuses on achieving a cure while minimizing long-term toxicity. If the disease proves refractory, high-dose chemotherapy followed by an autologous stem cell transplant is utilized to rescue the patient’s hematopoietic system.
Multiple Myeloma
Treatment for Multiple Myeloma focuses on controlling plasma cell growth and managing bone-related complications. Experts advise a combination of proteasome inhibitors, immunomodulatory drugs, and steroids to achieve deep remission. For eligible candidates, an autologous bone marrow transplant is considered the gold standard for consolidation. Additionally, supportive care involving bisphosphonates is provided to maintain bone health and improve the patient’s overall quality of life.
Advanced Diagnostic Facilities Available at Best Blood Cancer Hospital in India
Comprehensive Treatment Services at the Best Blood Cancer Hospital in India
Artemis Hospitals provides a spectrum of oncology services designed to address the complex nature of haematological malignancies through clinical excellence. Our comprehensive approach combines advanced medical technology with personalised care plans to deliver superior outcomes at the premier blood cancer centre in India.
Chemotherapy and Targeted Therapy
Chemotherapy utilises potent cytotoxic drugs to systemically eliminate rapidly dividing malignant cells by disrupting their DNA replication or cell division cycles. In contrast, Targeted Therapy involves small-molecule inhibitors or monoclonal antibodies designed to interfere with specific molecular targets, such as mutated proteins or signalling pathways (e.g., tyrosine kinase inhibitors). This precision approach minimizes damage to healthy cells, offering a more focused treatment strategy for the patient while reducing systemic toxicity.
Immunotherapy and Precision Medicine
Immunotherapy leverages the patient's own immune system to identify and destroy cancer cells using agents like immune checkpoint inhibitors or CAR-T cell therapy. This is often integrated with Precision Medicine, which uses genetic profiling and bioinformatics to tailor medical care based on the specific genetic mutations of a tumour. By understanding the unique molecular signature of the disease, clinicians can select the most effective biological agents, significantly improving clinical outcomes.
Bone Marrow Transplant (BMT)
A Bone Marrow Transplant, or Hematopoietic Stem Cell Transplant, involves replacing the patient’s damaged or diseased bone marrow with healthy stem cells. This process begins with high-dose "conditioning" therapy to ablate the existing marrow, followed by the infusion of autologous or allogeneic stem cells. These cells migrate to the bone marrow space, initiating haematopoiesis to regenerate a functional blood and immune system within a sterile, controlled environment.
Supportive and Palliative Care
Supportive and Palliative Care focuses on optimizing the quality of life by managing the physical and emotional side effects of blood cancer. This involves multidisciplinary interventions, including specialized pain management, nutritional support, and the treatment of therapy-induced complications like anaemia or neutropenia. For the patient, this layer of care runs concurrently with curative treatments to address distress, ensure comfort, and support overall holistic well-being during the recovery process.
Why Choose Artemis Hospitals as the Best Blood Cancer Hospital in India?
Artemis Hospitals stands out as a leader in haematological oncology by combining world-class expertise with cutting-edge medical technology. The hospital houses a dedicated team of internationally trained haematologists and transplant surgeons specialising in complex blood disorders.
By using advanced techniques such as Allogeneic and Autologous Bone Marrow Transplants, along with precision tools like Flow Cytometry and Molecular Diagnostics, the facility ensures highly accurate staging and personalised therapy. For the patient, this integration of a high-end HEPA-filtered BMT unit and a multidisciplinary team provides the safest environment for achieving successful long-term remission.
To book an appointment, call +91 98004 00498.
Article by Dr. Sukriti Gupta
Sr. Consultant - Hematology, Paediatric Haemato-Oncology & BMT
Artemis Hospitals
